New hope for kidney transplants: drug switch may protect heart and blood vessels
NCT ID NCT06291077
First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study looks at kidney transplant patients who take drugs to prevent organ rejection. Some take standard anticalcineurin drugs, which can harm blood vessels and raise heart risks. Others switch to a newer drug called belatacept. The goal is to see if belatacept improves blood vessel function over 6 months. About 44 adults will take part, and results could help doctors choose safer long-term treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.